These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 22766229)
1. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program. Rothman RD; Baggish AL; O'Callaghan C; Lowry PA; Bhatt AB; MacRae CA; Yannekis G; Sanborn DM; Mela T; Yeh RW; Palacios I; Vlahakes GJ; Fifer MA Am J Cardiol; 2012 Oct; 110(8):1169-74. PubMed ID: 22766229 [TBL] [Abstract][Full Text] [Related]
2. Short atrioventricular delay pacing therapy in young and old patients with hypertrophic obstructive cardiomyopathy: good long-term results and a low need for reinterventions. Javidgonbadi D; Abdon NJ; Andersson B; Schaufelberger M; Östman-Smith I Europace; 2018 Oct; 20(10):1683-1691. PubMed ID: 29121221 [TBL] [Abstract][Full Text] [Related]
3. Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. Ball W; Ivanov J; Rakowski H; Wigle ED; Linghorne M; Ralph-Edwards A; Williams WG; Schwartz L; Guttman A; Woo A J Am Coll Cardiol; 2011 Nov; 58(22):2313-21. PubMed ID: 22093509 [TBL] [Abstract][Full Text] [Related]
4. Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with β-blockade or verapamil. Sherrid MV; Shetty A; Winson G; Kim B; Musat D; Alviar CL; Homel P; Balaram SK; Swistel DG Circ Heart Fail; 2013 Jul; 6(4):694-702. PubMed ID: 23704138 [TBL] [Abstract][Full Text] [Related]
6. Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing In Cardiomyopathy. Gadler F; Linde C; Daubert C; McKenna W; Meisel E; Aliot E; Chojnowska L; Guize L; Gras D; Jeanrenaud X; Kappenberger L Eur Heart J; 1999 Jul; 20(14):1044-50. PubMed ID: 10381856 [TBL] [Abstract][Full Text] [Related]
7. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258 [TBL] [Abstract][Full Text] [Related]
8. [The long-term effects of dual-chamber stimulation in 8 patients with hypertrophic obstructive cardiomyopathy and symptoms refractory to medical therapy]. Capezzuto A; Guerra R; Pontillo D; Sassara M; Savelli MS; Castellani R; Scabbia EV Ital Heart J Suppl; 2000 Feb; 1(2):250-5. PubMed ID: 10731383 [TBL] [Abstract][Full Text] [Related]
9. Cardiac pacing in hypertrophic cardiomyopathy: a cohort with 24 years of follow-up. Silva LA; Fernández EA; Martinelli Filho M; Costa R; Siqueira S; Ianni BM; Mady C Arq Bras Cardiol; 2008 Oct; 91(4):250-6, 274-80. PubMed ID: 19009178 [TBL] [Abstract][Full Text] [Related]
11. [Transcoronary ablation of septal hypertrophy versus dual-chamber cardiac pacing for the treatment of aged patients with hypertrophic obstructive cardiomyopathy]. Gao YC; Li Y; Han ZH; Zhang XL; Zhao H; Jiang TY Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):333-6. PubMed ID: 17711659 [TBL] [Abstract][Full Text] [Related]
12. [The treatment of hypertrophic obstructive cardiomyopathy refractory to medical treatment by DDD pacing]. Tascón J; Albarrán A; Pérez-Carasa MA; Andreu J; Rodríguez J; Coma R; Cosío FG Rev Esp Cardiol; 1994 May; 47(5):294-302. PubMed ID: 8016438 [TBL] [Abstract][Full Text] [Related]